Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Erbium:YAG-assisted percutaneous absorption of triamcinolone acetonide in different dosage forms
TCTR20230417002Phase 4Unknown
- Sponsor
- Department of Dermatology, Siriraj Hospital
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide, sponsored by Department of Dermatology, Siriraj Hospital. Status: unknown.
02
Drugs
triamcinolone acetonide
Beyond the preview
Go deeper on TCTR20230417002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230417002.